COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04070326
Brief Title: A Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Pediatric Participants of 2 Years to Less Than (<) 12 Years of Age (SPRING)

First Submitted : August 26, 2019
First Submitted that Met QC Criteria : August 26, 2019
First Posted : August 28, 2019

Last Update Submitted that Met QC Criteria : September 24, 2019
Last Update Posted : September 26, 2019